These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9394818)

  • 1. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
    O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
    J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils.
    Neuman E; Huleatt JW; Jack RM
    J Immunol; 1990 Nov; 145(10):3325-32. PubMed ID: 1977799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles.
    Fällman M; Andersson R; Andersson T
    J Immunol; 1993 Jul; 151(1):330-8. PubMed ID: 8326130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
    Voice JK; Lachmann PJ
    Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production.
    Sehgal G; Zhang K; Todd RF; Boxer LA; Petty HR
    J Immunol; 1993 May; 150(10):4571-80. PubMed ID: 8097757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis.
    Detmers PA; Powell DE; Walz A; Clark-Lewis I; Baggiolini M; Cohn ZA
    J Immunol; 1991 Dec; 147(12):4211-7. PubMed ID: 1721641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence of human monocytes to haemodialysis membranes: LFA 1 (CD11a/CD18) CR1 (CD35) and CR3 (CD11b/CD18) triggering promotes the biosynthesis of platelet-activating factor and adherence.
    Tetta C; Tropea F; Camussi G; Neri R; Wratten ML; Sereni L; Silvestro L; Franceschi C; Haeffner-Cavaillon N
    Nephrol Dial Transplant; 1995; 10(9):1679-88. PubMed ID: 8559489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium fluoride reveals multiple pathways for regulation of surface expression of the C3b/C4b receptor (CR1) on human polymorphonuclear leukocytes.
    Okada K; Brown EJ
    J Immunol; 1988 Feb; 140(3):878-84. PubMed ID: 2963068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways.
    Zhang W; Lachmann PJ
    J Immunol; 1996 Apr; 156(7):2599-606. PubMed ID: 8786325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage.
    Danielsson C; Pascual M; French L; Steiger G; Schifferli JA
    Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors.
    Graham IL; Gresham HD; Brown EJ
    J Immunol; 1989 Apr; 142(7):2352-8. PubMed ID: 2538507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.